Herpes zoster ophthalmicus in Malawi.
OBJECTIVE
The objective was to describe the complications and outcomes of herpes zoster ophthalmicus in a population of young Africans with a high seroprevalence of human immunodeficiency virus type 1 in which treatment often is delayed and in which antiviral drugs are not available.


METHODS
Twenty-seven patients with herpes zoster ophthalmicus presenting consecutively to a large urban hospital were examined and followed. Treatment was limited to that which was locally available.


RESULTS
Visual outcomes were poor. Sixty-six percent of eyes had final visual acuity less than 20/60. Forty percent had light perception or no light perception visual acuity. Severe keratouveitis and corneal perforation were common and responsible for most poor visual outcomes.


CONCLUSIONS
Young Africans with herpes zoster ophthalmicus are at a high risk for significant visual loss.
Lewallen
S
S
International Eye Foundation, Blantyre, Malawi, Africa.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000328:Adult; D002701:Chloramphenicol / Q000008:administration & dosage; D003316:Corneal Diseases / Q000209:etiology; D005141:Eyelid Diseases / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D006563:Herpes Zoster Ophthalmicus / Q000150:complications / Q000188:drug therapy; D006786:Hospitals, Urban; D006801:Humans; D008295:Malawi; D008297:Male; D008875:Middle Aged; D009824:Ointments; D009883:Ophthalmic Solutions; D013752:Tetracycline / Q000008:administration & dosage; D013997:Time Factors; D014605:Uveitis / Q000209:etiology; D014786:Vision Disorders / Q000209:etiology; D014792:Visual Acuity
D000305:Adrenal Cortex Hormones; D009824:Ointments; D009883:Ophthalmic Solutions; D002701:Chloramphenicol; D013752:Tetracycline